{
    "Trade/Device Name(s)": [
        "VisuCon-F Low Fibrinogen Control Plasma"
    ],
    "Submitter Information": "Affinity Biologicals Inc.",
    "510(k) Number": "K150144",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGN"
    ],
    "Summary Letter Date": "February 1, 2016",
    "Summary Letter Received Date": "February 2, 2016",
    "Submission Date": "January 29, 2016",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Fibrinogen"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Clotting method of Clauss"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for VisuCon-F Low Fibrinogen Control Plasma, a frozen human plasma control for quantitative fibrinogen assays.",
    "Indications for Use Summary": "Intended for quality control of quantitative fibrinogen assays in the low abnormal range, for in vitro diagnostic use by trained laboratory personnel in clinical laboratories.",
    "fda_folder": "Hematology"
}